153 related articles for article (PubMed ID: 38240701)
1. Long non-coding RNA MEG3 acts as a suppressor in breast cancer by regulating miR-330/CNN1.
Yi D; Wang Z; Yang H; Wang R; Shi X; Liu Z; Xu F; Lu Q; Chu X; Sang J
Aging (Albany NY); 2024 Jan; 16(2):1318-1335. PubMed ID: 38240701
[TBL] [Abstract][Full Text] [Related]
2. The lncRNA MEG3/miR-16-5p/VGLL4 regulatory axis is involved in etoposide-induced senescence of tumor cells.
Tao Y; Yue P; Miao Y; Gao S; Wang B; Leng SX; Meng X; Zhang H
J Gene Med; 2021 Feb; 23(2):e3291. PubMed ID: 33141998
[TBL] [Abstract][Full Text] [Related]
3. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
[TBL] [Abstract][Full Text] [Related]
4. Niraparib restrains prostate cancer cell proliferation and metastasis and tumor growth in mice by regulating the lncRNA MEG3/miR-181-5p/GATA6 pathway.
Cheng J; Sun Y; Zhao H; Ren W; Gao D; Wang Z; Lv W; Dong Q
PeerJ; 2023; 11():e16314. PubMed ID: 38047026
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis.
Zhang X; Wu N; Wang J; Li Z
J Cell Mol Med; 2019 Oct; 23(10):6708-6719. PubMed ID: 31328388
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer.
Zhang W; Shi S; Jiang J; Li X; Lu H; Ren F
Biomed Pharmacother; 2017 Jul; 91():312-319. PubMed ID: 28463794
[TBL] [Abstract][Full Text] [Related]
7. miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway.
Wang Z; Li TE; Chen M; Pan JJ; Shen KW
Aging (Albany NY); 2020 Jan; 12(2):1867-1887. PubMed ID: 31986487
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA-211.
Ji L; Li X
J Cell Physiol; 2019 Dec; 234(12):22911-22920. PubMed ID: 31124134
[TBL] [Abstract][Full Text] [Related]
10. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
Wang L; Yu M; Zhao S
J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MEG3 inhibits the proliferation and migration abilities of colorectal cancer cells by competitively suppressing MiR-31 and reducing the binding of MiR-31 to target gene SFRP1.
Li Z; Zhao Z; Zhang G; Liu Y; Zheng S
Aging (Albany NY); 2023 Dec; 16(3):2061-2076. PubMed ID: 38309281
[TBL] [Abstract][Full Text] [Related]
12. lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p.
Long J; Pi X
Biomed Res Int; 2018; 2018():2086564. PubMed ID: 29808164
[TBL] [Abstract][Full Text] [Related]
13. LncRNA-MEG3 inhibits proliferation and metastasis by regulating miRNA-21 in gastric cancer.
Dan J; Wang J; Wang Y; Zhu M; Yang X; Peng Z; Jiang H; Chen L
Biomed Pharmacother; 2018 Mar; 99():931-938. PubMed ID: 29710493
[TBL] [Abstract][Full Text] [Related]
14. Upregulation LncRNA MEG3 expression suppresses proliferation and metastasis in melanoma via miR-208/SOX4.
Yang Y; Jin L; He J; Wang R; Wang Y; Bai J; Chen Y; Luo Z
Mol Cell Biochem; 2023 Feb; 478(2):407-414. PubMed ID: 35838912
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells.
Zhu M; Wang F; Mi H; Li L; Wang J; Han M; Gu Y
Cell Cycle; 2020 Dec; 19(23):3277-3288. PubMed ID: 33121324
[TBL] [Abstract][Full Text] [Related]
16. Participation of tumor suppressors long non-coding RNA MEG3, microRNA-377 and PTEN in glioma cell invasion and migration.
Wang D; Fu CW; Fan DQ
Pathol Res Pract; 2019 Oct; 215(10):152558. PubMed ID: 31378455
[TBL] [Abstract][Full Text] [Related]
17. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes.
Wang X; Li X; Wang Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649837
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Suppressive Function of lncRNA-MEG3 in Glioma Cells by Regulating miR-6088/SMARCB1 Axis.
Gong X; Huang MY
Biomed Res Int; 2020; 2020():4309161. PubMed ID: 32420340
[TBL] [Abstract][Full Text] [Related]
19. MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway.
Zhu M; Wang X; Gu Y; Wang F; Li L; Qiu X
Arch Biochem Biophys; 2019 Jan; 661():22-30. PubMed ID: 30389444
[TBL] [Abstract][Full Text] [Related]
20. m
Li Y; Lou S; Zhang J; Zhao S; Lou G
J Transl Med; 2024 Jan; 22(1):113. PubMed ID: 38281945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
